Avai Bio, Inc.
AVAI· OTC
Filed Jul 3, 2024 · 10-K · 94 days after period end · 0001740797-24-000031
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018 |
|---|---|---|---|---|
| Net Income | -$303.43K | $15.73K | — | -$28.84K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed Jul 3, 2024 · 94 d after period end